−0.10 TWD
−43.82 M TWD
1.03 M TWD
About MERCURY BIOPHARMACEUTICAL CORPORATI
Sector
Headquarters
New Taipei City
Founded
2019
Website
ISIN
TW0006932007
FIGI
BBG01BYYBXR8
Mercury Biopharmaceutical Corp. manufactures pharmaceutical products. It focuses on the development of drugs for unmet medical needs. It develop faster, lower side effects, and more in line with human needs for drugs. The company was founded in 2019 and is headquartered in New Taipei City. Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6932 is 13.20 TWD — it has decreased by −1.11% in the past 24 hours. Watch MERCURY BIOPHARMACEUTICAL CORPORATI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange MERCURY BIOPHARMACEUTICAL CORPORATI stocks are traded under the ticker 6932.
6932 stock has fallen by −3.94% compared to the previous week, the month change is a 1.52% rise, over the last year MERCURY BIOPHARMACEUTICAL CORPORATI has showed a −31.61% decrease.
6932 reached its all-time high on Mar 1, 2023 with the price of 29.50 TWD, and its all-time low was 6.60 TWD and was reached on Dec 23, 2022. View more price dynamics on 6932 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6932 stock is 3.86% volatile and has beta coefficient of −0.29. Track MERCURY BIOPHARMACEUTICAL CORPORATI stock price on the chart and check out the list of the most volatile stocks — is MERCURY BIOPHARMACEUTICAL CORPORATI there?
Yes, you can track MERCURY BIOPHARMACEUTICAL CORPORATI financials in yearly and quarterly reports right on TradingView.
6932 net income for the last half-year is −18.30 M TWD, while the previous report showed −25.11 M TWD of net income which accounts for 27.12% change. Track more MERCURY BIOPHARMACEUTICAL CORPORATI financial stats to get the full picture.
No, 6932 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 18.00 employees. See our rating of the largest employees — is MERCURY BIOPHARMACEUTICAL CORPORATI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MERCURY BIOPHARMACEUTICAL CORPORATI EBITDA is −41.21 M TWD, and current EBITDA margin is −4.03 K%. See more stats in MERCURY BIOPHARMACEUTICAL CORPORATI financial statements.
Like other stocks, 6932 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MERCURY BIOPHARMACEUTICAL CORPORATI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MERCURY BIOPHARMACEUTICAL CORPORATI technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MERCURY BIOPHARMACEUTICAL CORPORATI stock shows the sell signal. See more of MERCURY BIOPHARMACEUTICAL CORPORATI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.